title: [Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine].
authors: V
authors: V
authors: Leclercq
authors: S
authors: S
authors: Lacaille
authors: S
authors: S
authors: Delpierre
authors: E
authors: E
authors: Karoubi
authors: S
authors: S
authors: Legrain
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy*; D001927:Brain Diseases / Q000139:chemically induced* / Q000175:diagnosis; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy*; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D017291:Clarithromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D004347:Drug Interactions; D004569:Electroencephalography; D006801:Humans; D007049:Iatrogenic Disease; D008297:Male; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D018692:Antimanic Agents; D002220:Carbamazepine; D017291:Clarithromycin